These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer. Slattery ML, Sweeney C, Murtaugh M, Ma KN, Wolff RK, Potter JD, Caan BJ, Samowitz W. Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2936-42. PubMed ID: 16365013 [Abstract] [Full Text] [Related]
29. Variants of estrogen receptor alpha and beta genes modify the severity of sporadic breast cancer. Rezende LM, Marson FA, Lima CS, Bertuzzo CS. Gene; 2017 Apr 15; 608():73-78. PubMed ID: 28109853 [Abstract] [Full Text] [Related]
30. Influence of estrogen receptor alpha and progesterone receptor polymorphisms on the effects of hormone therapy on mammographic density. van Duijnhoven FJ, Peeters PH, Warren RM, Bingham SA, Uitterlinden AG, van Noord PA, Monninkhof EM, Grobbee DE, van Gils CH. Cancer Epidemiol Biomarkers Prev; 2006 Mar 15; 15(3):462-7. PubMed ID: 16537702 [Abstract] [Full Text] [Related]
31. Are polymorphisms in oestrogen receptors genes associated with lipid levels in response to hormone therapy? Smiderle L, Mattevi VS, Giovenardi M, Wender MC, Hutz MH, Almeida S. Gynecol Endocrinol; 2012 Aug 15; 28(8):644-8. PubMed ID: 22324545 [Abstract] [Full Text] [Related]
32. Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Gold B, Kalush F, Bergeron J, Scott K, Mitra N, Wilson K, Ellis N, Huang H, Chen M, Lippert R, Halldorsson BV, Woodworth B, White T, Clark AG, Parl FF, Broder S, Dean M, Offit K. Cancer Res; 2004 Dec 15; 64(24):8891-900. PubMed ID: 15604249 [Abstract] [Full Text] [Related]
33. Genetic polymorphisms of estrogen receptors alpha and beta and the risk of developing prostate cancer. Chae YK, Huang HY, Strickland P, Hoffman SC, Helzlsouer K. PLoS One; 2009 Aug 05; 4(8):e6523. PubMed ID: 19654868 [Abstract] [Full Text] [Related]
34. Polymorphisms in genes of the steroid hormone biosynthesis and metabolism pathways and endometrial cancer risk. Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, Attia J, Gilbert M, Hamann U, Scott RJ. Cancer Epidemiol; 2010 Jun 05; 34(3):328-37. PubMed ID: 20381444 [Abstract] [Full Text] [Related]
35. Steroid hormones polymorphisms and cholelithiasis in Greek population. Kitsiou-Tzeli S, Giannatou E, Spanos I, Nicolaidou P, Fretzayas A, Tzetis M, Lazaris D, Kanavakis E, Tsezou A. Liver Int; 2007 Feb 05; 27(1):61-8. PubMed ID: 17241382 [Abstract] [Full Text] [Related]
36. Genetic polymorphisms of ESR1, ESR2, CYP17A1, and CYP19A1 and the risk of breast cancer: a case control study from North India. Chattopadhyay S, Siddiqui S, Akhtar MS, Najm MZ, Deo SV, Shukla NK, Husain SA. Tumour Biol; 2014 May 05; 35(5):4517-27. PubMed ID: 24430361 [Abstract] [Full Text] [Related]
37. Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer. Udler MS, Azzato EM, Healey CS, Ahmed S, Pooley KA, Greenberg D, Shah M, Teschendorff AE, Caldas C, Dunning AM, Ostrander EA, Caporaso NE, Easton D, Pharoah PD. Int J Cancer; 2009 Dec 01; 125(11):2687-96. PubMed ID: 19551860 [Abstract] [Full Text] [Related]
38. Social memory associated with estrogen receptor polymorphisms in women. Karlsson S, Henningsson S, Hovey D, Zettergren A, Jonsson L, Cortes DS, Melke J, Laukka P, Fischer H, Westberg L. Soc Cogn Affect Neurosci; 2016 Jun 01; 11(6):877-83. PubMed ID: 26955855 [Abstract] [Full Text] [Related]
39. Inherited variations in AR, ESR1, and ESR2 genes are not associated with prostate cancer aggressiveness or with efficacy of androgen deprivation therapy. Sun T, Lee GS, Werner L, Pomerantz M, Oh WK, Kantoff PW, Freedman ML. Cancer Epidemiol Biomarkers Prev; 2010 Jul 01; 19(7):1871-8. PubMed ID: 20615892 [Abstract] [Full Text] [Related]
40. Haplotypes of the estrogen receptor beta gene and breast cancer risk. Breast and Prostate Cancer Cohort ConsortiumProgram in Molecular and Genetic Epidemiology, Epidemiology Department, Harvard School of Public Health, Boston, MA, USA., Cox DG, Bretsky P, Kraft P, Pharoah P, Albanes D, Altshuler D, Amiano P, Berglund G, Boeing H, Buring J, Burtt N, Calle EE, Canzian F, Chanock S, Clavel-Chapelon F, Colditz GA, Feigelson HS, Haiman CA, Hankinson SE, Hirschhorn J, Henderson BE, Hoover R, Hunter DJ, Kaaks R, Kolonel L, LeMarchand L, Lund E, Palli D, Peeters PH, Pike MC, Riboli E, Stram DO, Thun M, Tjonneland A, Travis RC, Trichopoulos D, Yeager M. Int J Cancer; 2008 Jan 15; 122(2):387-92. PubMed ID: 17935138 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]